SUBCUTANEOUS CORYNEBACTERIUM-PARVUM IN BLADDER-CANCER - CONTROLLED-STUDY OF ITS IMMUNOLOGICAL EFFECTS

被引:6
作者
PURVES, EC
SNELL, M
COPE, WA
ADDISON, IE
COPLAND, RFP
BERENBAUM, MC
机构
[1] ST MARYS HOSP,SCH MED,DEPT EXPTL PATHOL,LONDON W2 1PG,ENGLAND
[2] ST MARYS HOSP,DEPT UROL,LONDON W2 1PG,ENGLAND
来源
BRITISH JOURNAL OF UROLOGY | 1979年 / 51卷 / 04期
关键词
D O I
10.1111/j.1464-410X.1979.tb04709.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Summary— Fourteen out of 26 patients with invasive bladder cancer were randomly assigned to receive weekly subcutaneous injections of Corynebacterium parvum (CP) in addition to standard treatment. Peripheral blood T lymphocyte percentage, K cell activity, mitogen responsiveness, and monocyte and polymorph leucotaxis were measured at intervals over a period of 1 to 2 years. The only consistent difference between the CP‐treated patients and the controls was a slightly higher level of K cell activity in the former, who, however, fared rather worse than the controls in terms of survival. Copyright © 1979, Wiley Blackwell. All rights reserved
引用
收藏
页码:278 / 282
页数:5
相关论文
共 14 条
[1]   RAFT TECHNIQUE FOR CHEMOTAXIS - VERSATILE METHOD SUITABLE FOR CLINICAL STUDIES [J].
ADDISON, IE ;
BABBAGE, JW .
JOURNAL OF IMMUNOLOGICAL METHODS, 1976, 10 (04) :385-388
[2]  
BERENBAUM MC, 1976, CLIN EXP IMMUNOL, V26, P534
[3]  
Cerottini J C, 1974, Adv Immunol, V18, P67, DOI 10.1016/S0065-2776(08)60308-9
[4]  
FISHER RA, 1978, DEV BIOL STAND, V38, P461
[5]   INVITRO ANTITUMOR EFFECT OF LYMPHOID-CELLS FROM CORYNEBACTERIUM-PARVUM-TREATED MICE - EFFECT OF ROUTE OF C-PARVUM ADMINISTRATION [J].
GHAFFAR, A ;
CULLEN, RT .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1977, 58 (03) :717-720
[6]  
GORDON DS, 1978, DEV BIOL STAND, V38, P567
[7]   DAILY INTRAVENOUS INFUSIONS OF CORYNEBACTERIUM PARVUM IN 20 PATIENTS WITH DISSEMINATED CANCER - PRELIMINARY REPORT OF CLINICAL AND BIOLOGIC FINDINGS [J].
ISRAEL, L ;
EDELSTEIN, R ;
DEPIERRE, A ;
DIMITROV, N .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (01) :29-33
[8]  
MEDENICA R, 1978, DEV BIOL STAND, V38, P483
[9]  
MINTON JP, 1976, CLIN EXP IMMUNOL, V24, P441
[10]   DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .1. INTRODUCTION AND DESIGN [J].
PETO, R ;
PIKE, MC ;
ARMITAGE, P ;
BRESLOW, NE ;
COX, DR ;
HOWARD, SV ;
MANTEL, N ;
MCPHERSON, K ;
PETO, J ;
SMITH, PG .
BRITISH JOURNAL OF CANCER, 1976, 34 (06) :585-612